» Articles » PMID: 38272595

Type 1 Diabetes Screening and Diagnosis

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2024 Jan 25
PMID 38272595
Authors
Affiliations
Soon will be listed here.
Abstract

Those with concerning signs or symptoms should be evaluated for type 1 diabetes (T1D). Those with first-degree relatives with T1D or based on the presence of high-risk genes are at increased risk and benefit from screening. Universal screening should be considered in light of new potential therapies to delay disease progression. Although oral glucose tolerance test is the gold standard for T1D staging, there are multiple tools available when oral glucose tolerance test is not feasible. Risk score calculations increase the ability to predict disease progression. Testing should be repeated when symptoms of overt diabetes mellitus are not present.

Citing Articles

Insights into Knowledge and Attitudes About Autoantibody Screening from People Affected by Type 1 Diabetes: A Brief Report.

Kelly C, Wolf W, Cornelius E, Peter M, Chapman K, Dunne J Diabetes Ther. 2024; 15(10):2249-2261.

PMID: 39190273 PMC: 11410738. DOI: 10.1007/s13300-024-01637-z.